CUSP/p63 expression in basal cell carcinoma

Experimental Dermatology

Volumn 11, Issue 3, 2002, Pages 203-208

  Dellavalle, Robert P ^a,d   Walsh, Patrick ^a,d   Marchbank, Angela ^a   Grayson, Timothy E ^a   Su, Lih Jen ^a   Parker, Eva R ^a   DeGregori, James ^a,b   Penheiter, Kristi ^a   Aszterbaum, Michelle ^c   Epstein Jr , Ervin H ^c   Lee, Lela A ^a,e  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Hedgehog; p53; p63; Skin cancer

Indexed keywords

CHRONIC ULCERATIVE STOMATITIS PROTEIN; ISOPROTEIN; MESSENGER RNA; PROTEIN P63; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; CKAP4 PROTEIN, HUMAN; DNA BINDING PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; RNA; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRP63 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CONTROLLED STUDY; EPIDERMIS CELL; FIBROMA; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; SEBACEOUS NEVUS; SEBORRHEIC KERATOSIS; SEQUENCE ANALYSIS; SKIN BIOPSY; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; STOMATITIS; VERRUCA PLANA JUVENILIS; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; PATHOLOGY; SKIN; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

ANIMALS; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; MICE; PHOSPHOPROTEINS; RNA, NEOPLASM; SKIN; SKIN NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036615505     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110302.x     Document Type: Article

References (25)

1. Donehower L, Harvey M, Slagle B, McArthur J, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992: 356: 215-221.
2. Yang A, Schweitzer R, Sun D et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999: 398: 714-718.
3. Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999: 398: 708-713.
4. Celli J, Duijf P, Hamel B et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999: 99: 143-153.
5. Yang A, Kaghad M, Wang Y et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998: 2: 305-316.
6. Dellavalle R P, Egbert T, Marchbank A, Su L-J, Lee L A, Walsh P. CUSP/P63 expression in rat and human tissues. J Derm Sci 2001: 27: 82-87.
7. Park B J, Lee S J, Kim J I et al. Frequent alteration of p63 expression in human primary bladder carcinomas. Can Res 2000: 60: 3370-3374.
8. O'Connell J T, Mutter G L, Cviko A et al. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: A study with the p53 homologue p63. Gyn Onc 2001: 80: 30-36.
9. Wang T Y, Chen B F, Yang Y C et al. Histologic and immunophenotype classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. Human Path 2001: 32: 479-486.
10. Tron V, Li G, Ho V, Trotter M. Ultraviolet radiation-induced p53 responses in the epidermis are differentiation-dependent. J Cut Med Surg 1999: 3: 280-283.
11. Kaelin W Jr. The p53 family. Oncogene 1999: 18: 7701-7705.
12. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991: 253: 49-53.
13. Tani M, Shimizu K, Kawahara C et al. Mutation and expression of the p51 gene in human lung cancer. Neoplasia 1999: 1: 71-79.
14. Hagiwara K, McMenamin M, Miura K, Harris C. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 1999: 59: 4165-4169.
15. Osada M, Ohba M, Kawahara C et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998: 4: 839-843.
16. Lee L, Walsh P, Prater C et al. Characterization of an autoantigen associated with chronic ulcerative stomatitis: The CUSP autoantigen is a member of the p53 family. J Invest Dermatol 1999: 113: 146-151.
17. Chorzelski T, Olszewska M, Jarzabek-Chorzelska M, Jablonska S. Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. Eur J Dermatol 1998: 8: 261-265.
18. Liefer K M, Koster M I, Wang X J, Yang A, McKeon F, Roop D R. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 2000: 60: 4016-4020.
19. Aszterbaum M, Epstein J, Oro A et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999: 5: 1285-1291.
20. Hagiwara K, McMenamin M G, Miura K, Harris C C. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Can Res 1999: 59: 4165-4169.
21. Senoo M, Tsuchiya I, Matsumura Y et al. Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: Expression of Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour supressor p51. Br J Cancer 2001: 84: 1235-1241.
22. Johnson R, Rothman A, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996: 272: 1668-1671.
23. Xin H, Matt D, Qin J Z, Burg G, Boni R. The sebaceous nevus, a nevus with deletions of the PTCH gene. Cancer Res 1999: 59: 1834-1836.
24. Kallassy M, Toftgard R, Ueda M et al. Patched (ptch)-associated preferential expression of smoothened in human basal cell carcinoma of the skin. Cancer Res 1997: 57: 4731-4735.
25. Fan H, Khavari P. Sonic Hedgehog opposes epithelial cell cycle arrest. J Cell Biol 1999: 147: 71-76.